Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Biomed Pharmacother. 2016 Dec 29;87:58–72. doi: 10.1016/j.biopha.2016.12.083

Fig. 5.

Fig. 5

Maximum intensity microSPECT tumor and microCT skeletal fusion coronal, whole-body images of PC-3 tumor-bearing SCID mice at 20 h post-tail vein injection of [RGD-Glu-[111InDO3A]-6-Ahx-RM2] (left) and [RGD-Glu-[177Lu-DO3A]-6-Ahx-RM2] (right). Tumors are indicated by arrows.

Reproduced with permission from [93].